Investors Buy Henry Schein, Inc. (NASDAQ:HSIC) on Weakness
Investors purchased shares of Henry Schein, Inc. (NASDAQ:HSIC) on weakness during trading on Wednesday. $61.37 million flowed into the stock on the tick-up and $35.19 million flowed out of the stock on the tick-down, for a money net flow of $26.18 million into the stock. Of all equities tracked, Henry Schein had the 25th highest net in-flow for the day. Henry Schein traded down ($4.37) for the day and closed at $169.65
HSIC has been the topic of several research reports. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday. Northcoast Research upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price target on the stock in a research report on Monday. BidaskClub cut shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, August 2nd. Jefferies Group LLC restated a “hold” rating and issued a $177.00 price target on shares of Henry Schein in a research report on Friday, July 21st. Finally, Piper Jaffray Companies initiated coverage on shares of Henry Schein in a research report on Monday, June 12th. They issued a “neutral” rating and a $200.00 price target on the stock. One analyst has rated the stock with a sell rating, ten have given a hold rating and seven have assigned a buy rating to the stock. Henry Schein has a consensus rating of “Hold” and an average target price of $185.56.
The company has a 50-day moving average of $183.03 and a 200-day moving average of $174.57. The stock has a market capitalization of $13.46 billion, a P/E ratio of 25.78 and a beta of 1.09.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 8th. The company reported $1.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.73 by $0.02. The business had revenue of $3.06 billion during the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.74% and a net margin of 4.53%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.64 EPS. On average, equities research analysts anticipate that Henry Schein, Inc. will post $7.29 EPS for the current fiscal year.
In other news, EVP Gerald A. Benjamin sold 12,578 shares of Henry Schein stock in a transaction dated Thursday, May 11th. The stock was sold at an average price of $175.10, for a total value of $2,202,407.80. Following the completion of the transaction, the executive vice president now owns 44,061 shares in the company, valued at approximately $7,715,081.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.27% of the company’s stock.
Institutional investors have recently made changes to their positions in the stock. Fiduciary Trust Co. boosted its position in shares of Henry Schein by 16.1% in the second quarter. Fiduciary Trust Co. now owns 2,527 shares of the company’s stock valued at $462,000 after buying an additional 350 shares during the last quarter. Meiji Yasuda Life Insurance Co boosted its position in shares of Henry Schein by 10.4% in the second quarter. Meiji Yasuda Life Insurance Co now owns 2,130 shares of the company’s stock valued at $390,000 after buying an additional 200 shares during the last quarter. Bradley Foster & Sargent Inc. CT boosted its position in shares of Henry Schein by 2.1% in the second quarter. Bradley Foster & Sargent Inc. CT now owns 33,106 shares of the company’s stock valued at $6,059,000 after buying an additional 690 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of Henry Schein by 0.3% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,894 shares of the company’s stock valued at $1,079,000 after buying an additional 19 shares during the last quarter. Finally, Banque Pictet & Cie SA boosted its position in shares of Henry Schein by 22.4% in the second quarter. Banque Pictet & Cie SA now owns 3,000 shares of the company’s stock valued at $549,000 after buying an additional 550 shares during the last quarter. Institutional investors and hedge funds own 90.87% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was originally published by Watch List News and is owned by of Watch List News. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.watchlistnews.com/investors-buy-henry-schein-inc-nasdaqhsic-on-weakness/1466683.html.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.